mHealth Intervento sull'attività fisica per i giovani sopravvissuti al cancro (AYA-PACT)
Adolescenti e giovani adulti che diventano fisicamente attivi dopo la prova del cancro
In this randomized controlled trial the investigators will determine whether a mobile health intervention can increase physical activity levels in AYA cancer survivors over a one year period. The investigators will recruit 320 cancer survivors in Alberta who were diagnosed with a first cancer between the ages of 15 to 39 years and are within one year of treatment completion. Participants will be randomized into either the control group (educational information) or the intervention group (educational information; personalized physical activity plan; activity tracker watch; access to a private, online survivor community; motivational text messages and check-in calls/e-mails). All participants will complete fitness testing and questionnaires at baseline, 6 months and 12 months. A final measurement at 24 months will test long-term effectiveness.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Background:
There is a need for adolescent and young adult (AYA) cancer research because the number of new cancers in young people is increasing and the survivor population is growing. Interventions that try to reduce problems that affect people after cancer are particularly important since its treatments can have negative effects on survivors' physical and mental health even decades after diagnosis.
Aim:
Given the many positive effects of physical activity (e.g. improved fitness and quality of life), the study aims to encourage AYA cancer survivors to be more physically active as they shift from treatment to survivorship care. The main goal of this study is to see if a home-based, mobile health (mHealth) physical activity intervention can increase physical activity levels by at least 90 minutes/week compared to baseline in AYA cancer survivors.
Methods:
The investigators will conduct a two-center randomized controlled trial of 320 AYA cancer survivors. Participants (N=320) will be Albertan residents, diagnosed with a first cancer between the ages of 15 and 39 years, and within one year of cancer treatment completion. At the start of the study, participants will complete fitness testing and questionnaires. Participants will then be randomly put into either a control or intervention group. The control group will receive educational information only. The intervention group will also receive a personalized physical activity plan, an activity tracker watch, access to a private, online survivor community, motivational text messages and check-in calls/e-mails. Fitness testing and questionnaires will be repeated at 6 and 12 months to see if the intervention increased physical activity levels and improved health outcomes among the participants in the intervention group compared to controls. A final measurement at 24 months will test long-term use.
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Alberta
-
Calgary, Alberta, Canada, T2N5G2
- Arthur J.E. Child Comprehensive Cancer Centre
-
Edmonton, Alberta, Canada, T6G2H9
- University of Alberta
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Lives in Alberta
- Diagnosed with invasive malignancy in Alberta
- Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention) in the last 12 months, except for "maintenance" therapy to prevent recurrences
- Have the ability to read, write and speak English
- Have access to the Internet on at least a weekly basis
- Have a mobile phone with a text messaging plan
- Willing to be randomized to either arm.
Exclusion Criteria:
- Health problems which preclude the ability to walk for physical activity, as measured by the Physical Activity Readiness Questionnaire (PAR-Q)
- Currently pregnant or planning to become pregnant within the next 6 months
- Currently taking part in > 300 minutes/week of moderate-to-vigorous intensity physical activity on a regular basis
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: mHealth Physical Activity Intervention
The intervention arm will receive a 12 month mobile health (mHealth) physical activity intervention with a goal of increasing their moderate-vigorous intensity physical activity levels by 90 minutes per week above baseline. |
The intervention includes a physical activity prescription, a Polar activity tracker watch, access to a private AYA cancer survivor community through the Polar Flow community platform, mHealth nudges and surveys via text messaging, and regular phone or email contact from study staff. |
|
Nessun intervento: Control
Controls received "standard of care" from their medical team and were not provided with any physical activity guidance. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes in weekly minutes of moderate-vigorous intensity physical activity
Lasso di tempo: Baseline to 12 months
|
Measured by ActiGraph |
Baseline to 12 months
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Changes in weekly minutes of moderate-vigorous intensity physical activity
Lasso di tempo: Baseline to 6 months and 24 months.
|
Measured by ActiGraph |
Baseline to 6 months and 24 months.
|
|
Changes in weekly minutes of sleep
Lasso di tempo: Baseline, 6 months, 12 months, 24 months
|
Measured by ActiGraph |
Baseline, 6 months, 12 months, 24 months
|
|
Changes in weekly minutes of sedentary time
Lasso di tempo: Baseline, 6 months,12 months, 24 months
|
Measured by ActiGraph |
Baseline, 6 months,12 months, 24 months
|
|
Changes in moderate-vigorous physical activity using the self-administered Past Year Total Physical Activity Questionnaire (PYTPAQ).
Lasso di tempo: Baseline, 12 months, 24 months.
|
Met-Hours per week and hours per week of moderate-vigorous physical activity |
Baseline, 12 months, 24 months.
|
|
Changes in the Pittsburgh Sleep Quality Index (PSQI) Global Sleep Quality Score
Lasso di tempo: Baseline, 6 months,12 months
|
Global score range is 0 to 23 where higher scores indicate worse sleep quality |
Baseline, 6 months,12 months
|
|
Changes in weight
Lasso di tempo: Baseline, 6 months,12 months
|
Measured in kilograms |
Baseline, 6 months,12 months
|
|
Changes in body mass index (BMI)
Lasso di tempo: Baseline, 6 months,12 months
|
Measured by combining height (meters) and weight (kilograms) and reported in kg/m2 |
Baseline, 6 months,12 months
|
|
Changes in waist and hip circumference
Lasso di tempo: Baseline, 6 months,12 months
|
Measured in centimeters |
Baseline, 6 months,12 months
|
|
Changes in cardiorespiratory fitness
Lasso di tempo: Baseline, 6 months,12 months
|
Measured by peak oxygen consumption in relative (ml/kg/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation |
Baseline, 6 months,12 months
|
|
Changes in cardiorespiratory fitness
Lasso di tempo: Baseline, 6 months,12 months
|
Measured by peak oxygen consumption in absolute (L/min) values using the modified Bruce protocol treadmill test with direct measures of gas exchange and ventilation |
Baseline, 6 months,12 months
|
|
Changes in grip strength
Lasso di tempo: Baseline, 6 months,12 months
|
Measured in kilograms using a hand dynamometer |
Baseline, 6 months,12 months
|
|
Changes in upper body muscular strength
Lasso di tempo: Baseline, 6 months,12 months
|
Measured in kilograms using an 8-10 repetition maximum (RM) chest press test used to predict 1-RM |
Baseline, 6 months,12 months
|
|
Changes in upper body muscular endurance
Lasso di tempo: Baseline, 6 months,12 months
|
Measured in kilograms using the maximum number of chest press repetitions completed at 50% of estimated 1-RM |
Baseline, 6 months,12 months
|
|
Changes in lower body muscular strength
Lasso di tempo: Baseline, 6 months,12 months
|
Measured in kilograms using an 8-10 repetition maximum (RM) leg press test used to predict 1-RM |
Baseline, 6 months,12 months
|
|
Changes in lower body muscular endurance
Lasso di tempo: Baseline, 6 months,12 months
|
Measured in kilograms using the maximum number of leg press repetitions completed at 70% of estimated 1-RM |
Baseline, 6 months,12 months
|
|
Changes in frailty
Lasso di tempo: Baseline, 6 months,12 months
|
Defined according to the Fried phenotype which takes into account low lean muscle mass, exhaustion, low energy expenditure, walking limitations, and weakness |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Mental Health Component subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better mental health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Physical Health Component subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better physical health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Physical Functioning subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Role-physical subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Bodily Pain subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate less pain |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) General Health subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better health |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Vitality subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher vitality |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Social Functioning subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 (SF-36) Role-emotional subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate higher functioning |
Baseline, 6 months,12 months
|
|
Changes in the Short Form 36 Mental Health subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 100 where higher scores indicate better mental health |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Impact of Cancer subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Physical subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Emotional subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Cognitive subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Cancer Distress Scales for AYAs Cancer Worry subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Scores range from 0 to 100 where higher scores indicate more distress |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function Perceived Cognitive Impairment subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 72. Higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Comments From Others subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 16 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Perceived Cognitive Abilities subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 36 where higher scores indicate poorer cognition |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Cognitive Function (FACT-Cog) Impact on Quality of Life subscale
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 16 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Functional Assessment of Cancer Therapy Fatigue (FACT-F)
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 52 where higher scores indicate better quality of life. |
Baseline, 6 months,12 months
|
|
Changes in the Comprehensive Score for Financial Toxicity (COST)
Lasso di tempo: Baseline, 6 months,12 months
|
Score range is from 0 to 44 where higher scores indicate better financial wellbeing |
Baseline, 6 months,12 months
|
|
Changes in fear of cancer recurrence - short form (FCRI-SF)
Lasso di tempo: Baseline, 6 months, 12 months
|
Score range is from 0 - 36 where higher scores indicate greater fear of recurrence severity. |
Baseline, 6 months, 12 months
|
|
Changes in Sedentary Behaviour using a 7 day Sedentary Recall
Lasso di tempo: Baseline, 6 months, 12 months.
|
Hours of sitting during the week and on weekends for the following categories: (1) traveling to work, (2) at work or school, (3) watching television, (4) using a computer, and (5) leisure time not including television. |
Baseline, 6 months, 12 months.
|
|
Changes in environmental barriers that prevent or limit walking and cycling where a person lives or works - PANES Questionnaire
Lasso di tempo: Baseline, 6 months, 12 months.
|
Score range is from 1 to 4 with higher values indicating greater environmental support for physical activity. |
Baseline, 6 months, 12 months.
|
|
Changes in Exercise Self-Efficacy - Subscale (FITNET Questionnaire)
Lasso di tempo: Baseline, 6 months, 12 months
|
Range of scores from 11 to 55 with higher scores indicated higher self-efficacy. |
Baseline, 6 months, 12 months
|
|
Changes in Social Support from Family and Friends related to Exercise - Subscale (FITNET Questionnaire)
Lasso di tempo: Baseline, 6 months, 12 months.
|
Range of scores from 10 to 50 with higher scores indicating more support. |
Baseline, 6 months, 12 months.
|
|
Changes in Self-Monitoring related to setting exercise goals and planning exercise activities - Subscale (FITNET Questionnaire)
Lasso di tempo: Baseline, 6 months, 12 months.
|
Range of scores from 12 to 60 with higher scores indicating more self-monitoring. |
Baseline, 6 months, 12 months.
|
Collaboratori e investigatori
Sponsor
Sponsor
Collaboratori
Collaboratori
Investigatori
Investigatori
- Direttore dello studio: Miranda Fidler-Benaoudia, PhD, Cancer Care Alberta
- Investigatore principale: Christine Friedenreich, PhD, Cancer Care Alberta
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- HREBA.CC-20-0397
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .